ORAGENICS INC — Director's Dealing 2022

Aug 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2022-07-29

Reporting Person: Telling Fred (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-29	Non-Employee Director Option (Right to Buy)	$0.3562	A	220000	Acquired	2032-07-29	Common Stock (220000)	Direct

Footnotes

F1: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022.